Entero Healthcare Mops Up Rs 716.4 Crore From Anchor Investors Ahead Of IPO
Entero Healthcare Solutions Ltd. has raised Rs 716.4 crore from anchor investors, ahead of its initial public offering.
The company allotted 56.94 lakh shares at Rs 1,258 apiece to 25 anchor investors.
Capital Group-backed Smallcap World Fund got the highest allocation of 23.19%, while the Government of Singapore secured 20.72%.
Pioneer Investment Fund (6%), Cramignag Portfolio (5.93%), Monetary Authority of Singapore (2.55%), Allainz Global (4.18%) and Jupiter India (4.18%) are among the other marquee investors in the pre-IPO round fundraising.
The leading book managers for the anchor round were ICICI Securities Ltd., DAM Capital Advisers Ltd., Jefferies India Pvt., JM Financial Ltd., and SBI Capital Markets Ltd.
About Entero Healthcare IPO
Healthcare products distributor Entero Healthcare Solutions is launching its initial public offering on Friday.
The IPO is for Rs 1,600 crore, comprising fresh issue of Rs 1,000 crore and an offer for sale of 47.7 lakh shares, which would be around Rs 600 crore.
The price range for the IPO is Rs 1,195-1,258 per share, with a minimum application lot size of 11 shares.
Of the total IPO size, 75% is reserved for qualified institutional buyers, 10% for retail individual investors, and the remaining 15% is to be allotted to non-institutional investors.
The net proceeds from the issue will be utilised towards:
Repayment/prepayment, in full or part, of certain borrowings availed by the company.
Funding of long-term working capital requirements of the company and its subsidiaries during FY25 and FY26.
Pursuing inorganic growth initiatives through acquisitions.
General corporate purposes.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.